CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial. (Q48923891)
Jump to navigation
Jump to search
scientific article published in September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial. |
scientific article published in September 2008 |
Statements
CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial (English)
V Viglietta
K Bourcier
G J Buckle
B Healy
H L Weiner
1 September 2008